Brand Name: Remicade
Why is this drug prescribed?
Infliximab is used to treat moderate to severe Crohn’s disease and Crohn’s disease with fistulas if the patient has had an inadequate response to corticosteroids or immunosuppressants. It is also given for treatment of moderate to severe ulcerative colitis if the patient has had an inadequate response to corticosteroids or immunosuppressants.
How is this drug taken?
Infliximab must be prepared and administered by a health care professional. An initial course of one to three infusions will be given over the space of six to eight weeks. Depending on the response, maintenance infusions may be given every six to 12 weeks.
Infliximab must be administered into a vein in the arm. This drug must be administered over a period of at least 2 hours, and the patient must be monitored for 1 to 2 hours after the infusion is complete, with access to resuscitation measures. There have been reports of safe and effective 1 hour infusions but this type of shorter infusion is not available at all infusion clinics or centres.
What special precautions should I follow?
Before taking this medication, talk to your doctor and pharmacist about:
Allergies | Pregnancy/Breastfeeding |
|
|
Other medications | Medical conditions |
|
|
What are the side effects of this medication?
Although side effects from infliximab are uncommon, they can occur. Check with your doctor as soon as possible if any of the following side effects occur:
Most common:
|
Rare:
|
Contact your doctor and nurse immediately if any of the following occur:
These side effects typically occur during the infusion – this type of reaction usually responds well to slowing the infusion and treatment with acetamenophin (Tylenol) and an antihistamine.
How should this medication be stored?
This medication must be stored in the refrigerator and must not be frozen. Keep this medication out of reach and sight of children.
Special Instructions